ObjectivesTo systematically review the efficacy of acupuncture for improving migraine symptoms and cerebral blood flow velocity.MethodsCBM, CNKI, VIP, WanFang Data, PubMed, EMbase and The Cochrane Library databases were electronically searched to collect randomized controlled trials (RCTs) on acupuncture for improving migraine symptoms and cerebral blood flow velocity from inception to September, 2017. Two reviewers independently screened literature, extracted data and assessed risk of bias of included studies, then, meta-analysis was performed by using RevMan 5.3 software.ResultsA total of 17 RCTs involving 2 226 patients were included. The results of meta-analysis showed that, acupuncture could effectively reduce the frequency of migraine compared with placebo acupuncture (SMD=−0.97, 95%CI −1.60 to −0.34, P=0.002) and medicine group (SMD=−1.29, 95%CI −1.85 to −0.73, P<0.000 01). Acupuncture could shorten duration of headache compared with placebo acupuncture (SMD=−0.73, 95%CI −1.25 to −0.21, P=0.006) and medicine group (SMD=−0.88, 95%CI −1.32 to −0.45, P<0.000 1). Compared with placebo acupuncture, acupuncture could relieve headache intensity (SMD=−0.67, 95%CI −1.15 to −0.19, P=0.006). The acupuncture group was superior to the placebo acupuncture group (SMD=−10.99, 95%CI −16.62 to −5.36, P=0.000 1) and medicine group (SMD=−0.63, 95%CI −0.87 to −0.40, P<0.000 01) in improving the cerebral blood flow velocity.ConclusionsCurrent evidence shows that acupuncture can effectively reduce frequency of migraine, shorten duration of migraine, relieve intensity of migraine and improve cerebral blood flow velocity. Due to limited quality of the included studies, more high quality studies are required to verify above conclusion.
ObjectivesTo understand the quantitative measurement tools for active aging and compare the index construction, applicability and application of different tools domestically and abroad, so as to provide a scientific basis for the formulation and improvement of localized measurement tools for active aging.MethodsWe performed electronical searches on PubMed, Web of Science, Elsevier, CNKI, WanFang Data, VIP, and websites of WHO, European Commission, United Nations Economic Commission for Europe from April 2002 to November 2019. Two reviewers independently screened literature and extracted data according to inclusion and exclusion criteria, and conducted a qualitative analysis and comparison of the obtained measurement tools.ResultsA total of 36 researches were included, which involved 9 original active aging quantitative measurement tools. Specifically, 3 were from Thailand, 2 were from China, 1 was from the European Union, Russia, Australia and Finland, respectively. There were 2 to 3 dimensions of the tools, 3 to 10 items of primary measurement targets, and 11 to 177 items of measurement indicators. The construction of the dimension and first-level measurement goals were mainly based on the three pillars of health, participation, and security which composed WHO’s policy framework. The indicators of tools had measured the health, participation, and security targets except for the AAQ-CHN (2012) and AAL-Thai (2016) tools. Five age-specific indicators of the use of electronic information technology equipment, voluntary services, participation in political activities, access to health care services, and lifelong learning habits appeared in the EU tool. The AAI-EU's empirical applications and related 20 studies had been published mainly in Europe, Asia, and the Americas. AAI-Thai (2006) and AAI-Thai (2014) were used in empirical researches in Asia and China, respectively, and the 3rd and 4th studies were published.ConclusionsThe indicators' design of AAI-EU (2012) has the most contemporary characteristics, the most confirmatory research and widest application. The development of Chinese localized quantitative measurement tools should take advantage of the EU and other representative measurement tools.